AstraZeneca EBIT 2010-2024 | AZN

AstraZeneca EBIT for the quarter ending June 30, 2024 was $2.746B, a 11.81% increase year-over-year.

  • AstraZeneca 2023 EBIT was 8.193B, a 118.07% increase from 2022.
  • AstraZeneca 2022 EBIT was 3.757B, a 255.78% increase from 2021.
  • AstraZeneca 2021 EBIT was 1.056B, a 79.54% decline from 2020.

EBIT can be defined as earnings before interest and taxes.

AstraZeneca EBIT 2010-2024 | AZN

  • AstraZeneca 2023 EBIT was 8.193B, a 118.07% increase from 2022.
  • AstraZeneca 2022 EBIT was 3.757B, a 255.78% increase from 2021.
  • AstraZeneca 2021 EBIT was 1.056B, a 79.54% decline from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
AbbVie (ABBV)$352.5B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B